Clinical Trials

Sponsor(s): National Institute on Drug Abuse (NIDA)

Condition(s):

Bipolar affective disorder
Bipolar Disorder
Manic depression
Psychotic Disorder
Bipolar Disorders (Manic Depressive Disorder)
Affective Disorders
Mood Disorders
Psychosis

Purpose: The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 sessions in this trial, and is being conducted by front-line drug counselors, to test its effectiveness in a more community-based setting. The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT.

Eligibility:

Minimum Age:

18 Years

Maximum Age:

70 Years

Accepts Healthy Volunteers:

No

Inclusion Criteria:

- bipolar disorder substance dependence taking a mood stabilizer

Exclusion Criteria:

- acute psychosis no substance use in past 60 days no prescribing doctor will not be in
area for next 15 months lives too far away

Other Location(s): Belmont, Massachusetts United States

Terms: This is an abstract courtesy of ClinicalTrials.gov, a service of the US National Institute of Health Developed by the National Library of Medicine. ClinicalTrials.gov provides regularly updates information about federally and privately supported clinical research in human volunteers.